Paul Dickinson, together with Andreas Abend (Merck), will present the first session in the APS webinar series ‘Developing Clinically Relevant Dissolution Specifications (CRDS)’ on 19th January 2021.

Please see the flyer for further details on this and future webinars in the series.

The webinar series is brought to you by experts from the Pharmaceutical Industry and representatives from global Regulatory Agencies. It will be of relevance to Industry, Regulators, specialist technology providers, Private Sector and Academic colleagues. The aim is to share and discuss progress and challenges through scientific presentations and Q&A sessions. The webinars will cover the current state of scientific affairs in the field, emerging trends and identify areas where Industry and Regulators can engage to further harmonise and enable CRDS development moving forwards.

“I believe that clinically relevant specifications are good for patients, regulators and medicines manufacturers alike, so I am very happy to support this seminar series and grateful to the organising committee for their hard work and dedication to make it happen. This is a great opportunity to learn about this topic that is so important for successful drug product development” – Paul Dickinson

The webinar is free to Academy of Pharmaceutical Sciences members, or £60 for non-members. Visit  APS Events for registration.